These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25855708)

  • 1. Breast cancer prevention in the era of precision medicine.
    Narod SA
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855708
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.
    Garcia-Closas M; Gunsoy NB; Chatterjee N
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25392194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of hereditary breast cancer].
    Taguchi T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():610-4. PubMed ID: 17682218
    [No Abstract]   [Full Text] [Related]  

  • 4. The breast cancer chemoprevention debate.
    Schmidt C
    J Natl Cancer Inst; 2011 Nov; 103(22):1646-7. PubMed ID: 22025628
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing hormone-dependent breast cancer in high-risk women.
    Vogel VG; Lo S
    J Natl Cancer Inst; 2003 Jan; 95(2):91-3. PubMed ID: 12529335
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current perspective of chemoprevention in breast cancer].
    Asaga S; Jinno H; Sakata M; Kitajima M
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():627-32. PubMed ID: 17682221
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.
    Baker SG
    J Natl Cancer Inst; 2015 Jun; 107(6):djv127. PubMed ID: 25957379
    [No Abstract]   [Full Text] [Related]  

  • 8. Twenty-five years of breast cancer risk models and their applications.
    Gail MH
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25722355
    [No Abstract]   [Full Text] [Related]  

  • 9. Precision medicine meets public health: population screening for BRCA1 and BRCA2.
    Levy-Lahad E; Lahad A; King MC
    J Natl Cancer Inst; 2015 Jan; 107(1):420. PubMed ID: 25550384
    [No Abstract]   [Full Text] [Related]  

  • 10. Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama.
    Marchetti P; Di Rocco CZ; Ricevuto E; Bisegna R; Cianci G; Calista F; Sidoni T; Porzio G; Ficorella C
    Ann Oncol; 2004; 15 Suppl 1():I27-I34. PubMed ID: 15280184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer prevention in high-risk women: searching for new options.
    Nelson NJ
    J Natl Cancer Inst; 2011 May; 103(9):710-1. PubMed ID: 21515834
    [No Abstract]   [Full Text] [Related]  

  • 12. Independent assessment supports a role for tamoxifen in breast cancer risk reduction.
    Oncology (Williston Park); 1999 Sep; 13(9):1211. PubMed ID: 10509317
    [No Abstract]   [Full Text] [Related]  

  • 13. Honing the health message on BRCA mutations.
    Schmidt C
    J Natl Cancer Inst; 2013 Dec; 105(24):1843-4. PubMed ID: 24316597
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer facts.
    J Okla State Med Assoc; 2012 Oct; 105(10):411-2. PubMed ID: 23316677
    [No Abstract]   [Full Text] [Related]  

  • 15. Applying the Hippocratic Oath in breast cancer-The case for promoting prevention.
    Anampa JD; McEvoy MP; Feldman S; Sparano JA
    Breast J; 2019 Mar; 25(2):187-189. PubMed ID: 30834671
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.
    Mislowsky A; Domchek S; Stroede C; Bergey MR; Sonnad SS; Wu L; Tchou J
    Ann Surg Oncol; 2011 Mar; 18(3):745-51. PubMed ID: 20972632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic test and prophylactic treatment in breast cancer families].
    Miyoshi Y; Noguchi S
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):512-22. PubMed ID: 11977534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
    Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M
    J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
    [No Abstract]   [Full Text] [Related]  

  • 20. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.